• O Udruženju

Welcome

Forgot password?

Not a member? Join today

Logo
  • Početna
  • Limfom
    • Hronična limfocitna leukemija
    • Non hočkinski limfom
    • Hočkinski limfom
    • Koji je tvoj podtip?
  • Živeti sa limfomom
    • Korisni saveti
    • Ishrana hematoloških bolesnika
    • Prevencija
  • Kampanje
  • Resursi
    • Video edukacija
    • Brošure
    • Infografike i lifleti
  • Početna
  • Limfom
    • Hronična limfocitna leukemija
    • Non hočkinski limfom
    • Hočkinski limfom
    • Koji je tvoj podtip?
  • Živeti sa limfomom
    • Korisni saveti
    • Ishrana hematoloških bolesnika
    • Prevencija
  • Kampanje
  • Resursi
    • Video edukacija
    • Brošure
    • Infografike i lifleti

Nehočkinski limfom

06 Aug 2019
  • maja
  • Hočkinov limfom, Hronična limfocitna leukemija, Nehočkinski limfom

Body size and obesity during adulthood, and risk of lympho-haematopoietic cancers: an update of the WCRF-AICR systematic review of published prospective studies

Overweight and obesity are a global health problem. During the last 40 years, the number of obese adults increased from 100 million in 1975 (69

Pročitaj više

02 May 2019
  • maja
  • Hočkinov limfom, Hronična limfocitna leukemija, Nehočkinski limfom

BMT Societies Issue Recommendations on Posttransplant Maintenance in HL/NHL

The American Society for Blood and Marrow Transplantation (ASBMT), Center for International Blood and Marrow Transplant Research (CIBMTR), and

Pročitaj više

04 Dec 2018
  • maja
  • Nehočkinski limfom

Next-generation therapy for follicular lymphoma

Morschhauser et al report the safety and efficacy of lenalidomide in combination with obinutuzumab and establish the recommended phase 2 dose

Pročitaj više

Pretraga

Novosti

  • Body size and obesity during adulthood, and risk of lympho-haematopoietic cancers: an update of the WCRF-AICR systematic review of published prospective studies 08/06/2019
  • “Impressive” results of a new approach to relapsed or refractory Hodgkin lymphoma 06/14/2019
  • EBMT 2019 – Preliminary in-human evaluation of a CD19/CD22 dual CAR-T construct for B-NHL 05/02/2019
  • BMT Societies Issue Recommendations on Posttransplant Maintenance in HL/NHL 05/02/2019
  • Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study 03/15/2019

Arhiva

  • August 2019
  • June 2019
  • May 2019
  • March 2019
  • December 2018
  • October 2018
  • June 2018
  • April 2018
  • August 2017

Kalendar

December 2019
M T W T F S S
« Aug    
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Newsletter

Najnovije

Body size and obesity during adulthood, and risk of lympho-haematopoietic cancers: an update of the WCRF-AICR systematic review of published prospective studies

123 Days ago

“Impressive” results of a new approach to relapsed or refractory Hodgkin lymphoma

177 Days ago

EBMT 2019 – Preliminary in-human evaluation of a CD19/CD22 dual CAR-T construct for B-NHL

219 Days ago

Pratite nas

December 2019
M T W T F S S
« Aug    
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

LIPA

Tel. 060 022 2317

e-mail: lipaserbia@gmail.com

bloodcancer101@gmail.com

www.lipa.org.rs

www.bloodcancer101.org.rs

PRIJATELJI UDRUŽENJA